New pill aims to boost power of popular weight loss drugs
Disease control
Not yet recruiting
This study aims to see if adding a new oral medication called enobosarm to the injectable weight loss drug semaglutide helps people lose more weight than semaglutide alone. It will enroll 200 adults aged 65 and older with obesity. The main goal is to measure total body weight cha…
Phase: PHASE2 • Sponsor: Veru Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC